Diosmetin

CAS No. 520-34-3

Diosmetin( Diosmetol | Luteolin 4'-methyl ester )

Catalog No. M14827 CAS No. 520-34-3

Diosmetin is an O-methylated flavone, a chemical compound that can be found in the Caucasian vetch.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG 31 In Stock
50MG 43 In Stock
100MG 59 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Diosmetin
  • Note
    Research use only, not for human use.
  • Brief Description
    Diosmetin is an O-methylated flavone, a chemical compound that can be found in the Caucasian vetch.
  • Description
    Diosmetin is an O-methylated flavone, a chemical compound that can be found in the Caucasian vetch.It has been found to act as a weak TrkB receptor agonist.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Diosmetol | Luteolin 4'-methyl ester
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    P450
  • Recptor
    CYP1A1| TrkB
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    520-34-3
  • Formula Weight
    300.26
  • Molecular Formula
    C16H12O6
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 60 mg/mL (199.82 mM)
  • SMILES
    O=C1C=C(C2=CC=C(OC)C(O)=C2)OC3=CC(O)=CC(O)=C13
  • Chemical Name
    5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-chromen-4-one

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Jang SW, et al. Proc Natl Acad Sci U S A. 2010 Feb 9;107(6):2687-92.
molnova catalog
related products
  • Dihydromethysticin

    Dihydromethysticin is a kavalactone found in Piper methysticum.

  • 7-BFC

    7-BFC (7-Benzyloxy-4-(trifluoromethyl)coumarin) is a coumarin-like fluorescent substrate that serves as a biomarker for cytochrome P 450 and can be used to study CYP isoforms and cytochrome P 450 metabolism.

  • CDD3505

    CDD3505 increases high-density lipoprotein cholesterol by targeting hepatic CYP3A.